Comparative Effectiveness Research Clinical Resource Area

Comparative effectiveness research (CER), a type of research which evaluates drug, technologies and treatment options through decision analyses methodologies has been a focal point of healthcare reform policy. The American Recovery and Reinvestment Act of 2009 allocated 1.1 billion dollars to CER and established the Federal Coordinating Council for CER. Additionally the Institute of Medicine established the 100 initial national priorities for CER, many which are oncology related.   

These resources and reports provide information on this important and emerging area of research and health policy.